IPOs & Listings
Smoltek Nanotech Starts Trading on Nordic Growth Market, Eyes Börse Stuttgart Dual Listing
By News Desk ·
Key takeaways
- Smoltek Nanotech Holding AB began trading all its instruments on the Nordic Growth Market on October 26, 2026.
- The company intends to pursue a dual listing on Börse Stuttgart during the fourth quarter of 2026.
- Smoltek's shares trade on NGM under the ticker symbol SMOL.
Smoltek Nanotech Holding AB began trading all its instruments on the Nordic Growth Market on October 26, 2026, and intends to pursue a dual listing on Börse Stuttgart in the fourth quarter of 2026, according to news.cision.com.
Smoltek's NGM Trading Debut and Stuttgart Plan
Smoltek's Board of Directors and management evaluated various marketplaces for trading the Company's instruments throughout the year. The Board decided to apply for a listing on NGM, part of the Börse Stuttgart Group, as this is considered the optimal path toward the European capital market.
"Trading on NGM represents an important step toward a stronger presence in the European capital market. It increases the visibility and accessibility of Smoltek's shares for European investors and supports our ambition to build long-term shareholder value," says Oskar Säfström, Acting CEO of Smoltek Nanotech Holding AB.
Later in the fourth quarter of 2026, Smoltek also aims to apply for a dual listing on Börse Stuttgart. The objective is to further strengthen the Company's presence in the European capital market and facilitate trading in the Company's shares for European investors.
Börse Stuttgart's Seturion platform received an EU DLT trading and settlement license, enabling faster tokenized securities settlement, according to Cryptonews.
Smoltek's Funding and Patent Record
According to akta.pro company records, Smoltek conducted a rights issue of approximately SEK 60 million in June 2026 to accelerate commercialization in semiconductors and green hydrogen, with 85.5% secured via subscription commitments and a Mangold Fondkommission guarantee. The company was granted a European patent within the Interposer family in May 2026, securing CNF-MIM capacitor IP across all major global semiconductor markets. Smoltek has 98 granted patents after the European interposer patent approval.
| Date | Round | Amount |
|---|---|---|
| 2026-06 | Post-IPO equity | $8.4 million |
| 2026-06 | Post-IPO equity | $21,391 |
| 2026-04 | Post-IPO debt | $1.2 million |
| 2025-08 | Post-IPO equity | $69,986 |
Smoltek's Path to the Listing
On October 21, 2026, Nordic Growth Market NGM approved the listing of Smoltek Nanotech Holding AB, with trading set to begin October 26, 2026, according to news.cision.com. The company has 238,269,035 issued shares, and the listing includes a subscription option with trading ending February 11, 2027.
On July 14, 2026, Smoltek registered its rights issue and over-allotment, with BTU trading ending July 17, 2026, and warrants trading starting July 23, 2026, according to news.cision.com. An additional convertible loan conversion added 4,242,422 shares, raising share capital to about SEK 28.4 million.
On June 12, 2026, Smoltek's rights issue of units began, with a subscription period ending June 26, 2026, according to news.cision.com.
Smoltek's Fourth-Quarter 2026 Listing Application
Smoltek aims to apply for a dual listing on Börse Stuttgart later in the fourth quarter of 2026.